Supplementary material The Supplementary material for this article can be found online at: SUPPLEMENTARY FIGURE 1 Flow diagram of studies identified in our literature search (PubMed, Scopus, and Ovis) and included in this mini-review
When NAD levels decline, mitochondrial activity in neural tissue can become less efficient
As we age, we lack key amino acids needed to build glutathione, and can suffer from glutathione deficiency
Converting a peptide into a drug: strategies to improve stability and bioavailability
Chronic fatigue, irregular sleep, mood swings, cognitive decline, are nerve issues all symptoms of B-12 deficiency
Food and Drug Administrations Pharmacy Compounding Advisory Committee will meet July 23 and 24 to review whether seven peptides should be eligible for compounding under Section 503A of the Federal Food, Drug and Cosmetic Act